| abstract |
The invention relates to monoclonal antibodies directed against the human c-kit receptor, obtained from DSM ACC 2007, DSM ACC 2008 and DSM ACC 2009 cell lines, or which are capable of binding to the c-kit receptor in a equivalent to the antibodies produced by the DSM ACC 2007, DSM ACC 2008 or DSM ACC 2009 cell lines. small cells, process according to which a tissue sample is incubated with at least one monoclonal antibody, in accordance with the invention, against the c-kit receptor and the bound antibodies are then identified, according to known methods. |